These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 64374)

  • 1. [Blood bunaphthine during dynamic physical exercise and anti-arrhythmic action].
    Rossi P; Cernigliaro C; Rognoni G; Carcano G
    G Ital Cardiol; 1976; 6(7):1233-7. PubMed ID: 64374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations between plasmatic concentrations and antiarrhythmic effect of bunaphtine (author's transl)].
    Rossi P; Carcano G; Rognoni G; Cernigliaro C; Calcaterra G
    G Ital Cardiol; 1976; 6(6):1048-55. PubMed ID: 1022605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic evaluation of intravenous bunaphtine in man.
    Di Biase M; Scarcia A; Chiddo A; Nacci E; Favale S; Rizzon P
    Acta Cardiol; 1977; 32(2):105-20. PubMed ID: 302072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Bunaphtine on right atrial and ventricular monophasic action potentials in man. Preliminary note (author's transl)].
    Bonatti V; Finardi A; Cabasson J; Botti G
    G Ital Cardiol; 1976; 6(3):440-9. PubMed ID: 1010195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study of the mechanism of the action of Bunaphtine recording the myocardial monophasic action potentials in man. Conclusive report (author's transl)].
    Bonatti V; Finardi A; Cabasson J; Botti G
    G Ital Cardiol; 1976; 6(8):1378-83. PubMed ID: 1010248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Choice of a class I intravenous anti-arrhythmic drug in severe ventricular arrhythmias].
    Bernard R; Walter M; Renard M
    Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):647-52. PubMed ID: 2435202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-arrhythmic activity of bunaphtin].
    Franchini G; Storelli A; Pierfelice O; Latorre A; Fiandanese F; Rizzon P
    Boll Soc Ital Cardiol; 1974; 19(5):427-33. PubMed ID: 4619020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness and characteristics of the action of etmozin in treating extrasystole in middle-aged and elderly patients].
    Korkushko OV; Butenko AG; Kaukenas IK
    Ter Arkh; 1986; 58(6):65-70. PubMed ID: 2429380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of a new anti-arrhythmic drug, bunaftine, on intra-atrial, atrio-ventricular and intraventricular conduction of the stimulus].
    Grazi S; Romano S; Bonazzi O; Pozzoni L; Cavoretto D; Gardumi M; Sardella F
    Cardiol Prat; 1974; 25(3):213-8. PubMed ID: 4434374
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical pharmacokinetics of pyromecaine. Prolonged intravenous infusion and the relation between its antiarrhythmic effect and its concentration].
    Piotrovskiĭ VK; Blagodatskikh SV; Metelitsa VI; Smirnov VK; Gorshkov VA
    Farmakol Toksikol; 1985; 48(4):83-6. PubMed ID: 2412887
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA; Campos Peris JV; García García J; Jaen Armand E; Ruiz Ros JA; Salas Nieto J; Rodríguez Ruiz P; Marco Quiles J; Martínez Jérez M; Pico Aracil F
    Arch Inst Cardiol Mex; 1981; 51(4):371-6. PubMed ID: 7337481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polycentric clinical experimentation with a new anti-arrhythmia agent: bunaftide].
    Botti G
    Boll Soc Ital Cardiol; 1972; 17(11):1089-104. PubMed ID: 4620064
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative evaluation of the anti-arrhythmia effect of the antioxidant ionol (dibunol) in the arrhythmic form of neurocirculatory asthenia and stable exertion-induced stenocardia].
    Meerson FZ; Korochkin IM; Barbarash OL
    Sov Med; 1990; (3):67-70. PubMed ID: 1695023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences in the treatment of arrhythmias with bunaftine (Meregon)].
    Guarini A; Amodio F; Rivetti L; Bonfiglio N
    Minerva Cardioangiol; 1975 Dec; 23(12):932-6. PubMed ID: 1232589
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
    Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
    Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of bunaftine in the therapy of arrhythmia in patients with decompensated heart disease].
    Pisano E; Sulcis A; Sanna M
    Minerva Cardioangiol; 1975 Dec; 23(12):937-40. PubMed ID: 1232590
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute and long-term antiarrhythmia effect of encainide in chronic atrial extrasystole].
    Thale J; Klein H; Shanks RG; Bender F
    Z Kardiol; 1985 Apr; 74(4):220-7. PubMed ID: 2408392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aprindin, a new drug for the treatment of extrasystole. Studies at rest, after change of posture and during load].
    Bender F; Brisse B; Biechl E
    Med Klin; 1974 Jun; 69(25):1124-9. PubMed ID: 4135947
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of arrhythmias in myocardial infarct. Results of the use of bunaftine].
    De Cesare BL; Lovreglio V; Sannito N
    Minerva Med; 1976 Sep; 67(40):2625-35. PubMed ID: 967338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.